Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

Featured

Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab with VIR-7831 for COVID-19

28th January 2021

Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced a collaboration to evaluate a combination of two COVID-19...

DHL expands pharma capabilities in South Africa

by Content Team

19th January 2021

DHL expands pharma capabilities in South Africa

DHL has expanded its capabilities in South Africa by investing in new 10,000 m sq warehouse, which has pharma facilities,...

Baxter Biopharma Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine

by Content Team

19th January 2021

DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

Baxter International announced Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19...

Humanigen and EVERSANA collaborate for Covid-19 drug commercialisation

by Content Team

19th January 2021

Cancer Treatment Can Be Cloned For COVID-19

Clinical-stage biopharmaceutical company Humanigen and EVERSANA have entered a partnership to make available the former’s lead drug candidate, lenzilumab, to...

Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases

by Content Team

19th January 2021

Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases

Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced a partnership to identify and...

Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland

by Content Team

19th January 2021

Moderna Announces the EC's Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Swissmedic, the Swiss Agency for Therapeutic...

From “Approved” to “Available” – Innovations in Scaling Parenteral Drug Manufacturing

by Content Team

7th December 2020

Intravacc partners with Wageningen Bioveterinary Research and Utrecht University to develop an intranasal COVID-19 vaccine

The road to market for new drugs and pharmaceutical products is long and complicated. Each stage of drug development is...

GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

by Content Team

20th July 2020

GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles...